col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


147 Results       Page 1

 [1] 
Elsevier: Vacunas
  original article Date Title Authors   All Authors
1 [GO] 2026―Jul―31 Behavioral drivers of SARS-CoV-2 distribution post-returning Madurese migrants from Malaysia S.E. Kinasih, M.K. Romadhona, T. Koesbardiati, R. Ida, B.L.S.W. Wardhani, I. Wahyudi
2 [GO] 2026―Jul―25 Influence of nurse counseling on vaccination uptake in patients with chronic liver disease during the COVID-19 pandemic M.J. Sánchez-Iturri, A. Alcorta, E. Zapata, L. Martínez-Alcorta, C. Sarasqueta, A. Castiella
3 [GO] 2026―May―15 Situación actual y perspectivas de las vacunas auto-amplificables de ARN mensajero (aaARNm) frente al SARS-CoV-2 J. Reina, P. Fraile-Ribot
4 [GO] 2026―Feb―25 Filling the global vaccine research vacuum: Scientific denialism, pandemic risk, and the urgency of a new international immunization order H.M. Silva
5 [GO] 2026―Jan―28 The critical need for broad spectrum vaccines against emerging coronaviruses Balamurugan Shanmugaraj, Ashwini Malla, Balasubramanian Murugesan
6 [GO] 2025―Nov―11 C0165 ESTUDIO EPIDEMIOLÓGICO DE UN BROTE DE SARS-COV-2 VARIANTE ÓMICRON LINAJE BA.1.1 EN UN CENTRO SOCIOSANITARIO DE LA COMUNIDAD VALENCIANA José Luis Mendoza García, Noelia Rodriguez Blanco, Andreu Nolasco-Bonmatí, Jesus Manuel Sanchez-Mas, Jose Luis Duró-Torrijos
7 [GO] 2025―Nov―11 C0147 LA VACUNA FRENTE AL SARS-COV-2 EN POBLACIÓN ADULTA DISMINUYE LAS ENFERMEDADES CARDIOVASCULARES; UNA REVISIÓN SISTEMÁTICA Ester Arranz, Jerónimo Rodriguez-Beltrán
8 [GO] 2025―Nov―11 C0130 EVALUACIÓN DE LA COBERTURA VACUNAL FRENTE A SARS-COV-2 EN PACIENTES HOSPITALIZADOS POR INFECCIÓN RESPIRATORIA AGUDA FUERA DE TEMPORADA 2024-2025 Ximena Soledad Samaniego Vasquez, Sara Herranz Ulldemolins
9 [GO] 2025―Nov―11 C0106 IMPACTO DE VACUNACIÓN FRENTE A COVID-19 ENTRE PACIENTES CON TRASPLANTE DE PROGENITORES HEMATOPOYÉTICOS Y ONCOHEMATOLÓGICOS Abelardo Claudio Fernandez Chávez, Guillermo Ordoñez León, María Ysabel Mendoza Gómez, Paula Navarro López, Militza Alexandra Abzueta Millan, Jesús María Aranaz Andrés
10 [GO] 2025―Nov―11 C0003 ACEPTACIÓN DESIGUAL DE VACUNAS EN PACIENTES DE RIESGO: EL CASO DE LA COVID-19 EN UN ENTORNO HOSPITALARIO Alejandro de Arriba Fernández, Ainara Díaz Hernández, Ángel Henríquez Ojeda
11 [GO] 2025―Nov―11 C0056 EVOLUCIÓN DE LA VACUNACIÓN FRENTE A GRIPE Y COVID-19 EN TRABAJADORES SANITARIOS DE LA COMUNIDAD DE MADRID Amaya Sanchez Gomez, Alejandra López Zambrano, Jacinto Cano López, Soledad Cañellas Llabrés, María Angeles Gutiérrez Rodríguez, María C. Vázquez Torres, Marta Molina Olivas
12 [GO] 2025―Nov―11 C0151 CUANDO TROPEZAR TE AYUDA A MEJORAR: COBERTURA DE VACUNACIÓN FRENTE A GRIPE Y COVID-19 EN EMBARAZADAS Paula Cienfuegos González, María José Zapico Baragaño, María Fernández Prada, Julio Vázquez Rojo, Sofía García Rodríguez
13 [GO] 2025―Oct―10 Causality assessment of adverse events following immunization “AEFIs” linked to COVID-19 vaccines: clinical cases Ibtissem Nour ELhouda BEKHTI, Derouicha MATMOUR, EL KRALDIA Wafaa YAKOUB, Hadjer LARACHI, Yassine MERAD, Houari TOUMI
14 [GO] 2025―Jun―11 Modeling the booster vaccine effect on new COVID-19 variant management employs the Atangana-Baleanu-Caputo fractional derivative operator together with the Laplace-Adomian decomposition method M.O. Olayiwola, K.R. Tijani, M.O. Ogunniran, A.O. Yunus, E.A. Oluwafemi, M.O. Abanikanda, et al. (+2)
15 [GO] 2025―Jun―03 Cytokine production and TLR 7/8 gene expression following BBIBP-CorV COVID-19 vaccination Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
16 [GO] 2025―May―16 La vacunación como estrategia para el control de la pandemia por SARS-CoV-2 José Antonio Navarro-Alonso
17 [GO] 2025―Apr―23 A mathematical model for assessing vaccination's efficacy as a preventative strategy against newly emerging COVID-19 variants Akeem Olarewaju Yunus, Morufu Oyedunsi Olayiwola
18 [GO] 2025―Apr―06 Exploring structural proteins of Nipah, Lassa, and coronaviruses for multi-epitope vaccine design using immuno-informatics and in silico studies Ananya Saji, Sagaya Jansi Rozario, Balamurugan Shanmugaraj, Praveen Kumar Panthagani
19 [GO] 2025―Mar―19 Seasonal influenza in the wake of COVID-19: Redressing the H3N2 outbreak and its implications for public health Farid Rahimi, Amin Talebi Bezmin Abadi
20 [GO] 2025―Feb―28 Shaping health behavior and social connectedness during COVID-19 through media adaptation strategies in Indonesia Muhammad Saud, Irfan Wahyudi
21 [GO] 2025―Jan―18 Sustainability amidst pandemic: A qualitative approach on resilience strategies of cut flower farmers during the COVID-19 pandemic in Indonesia Rustinsyah Rustinsyah, Muhammad Adib, Ratna Azis Prasetyo, Abdullah Ibrahim
22 [GO] 2024―Nov―15 COVID-19 story: Entry and immune response Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
23 [GO] 2024―Oct―24 Evaluation of the effect of melatonin on patients with COVID-19 admitted to ICU: A double-blind randomized clinical trial Mahmoud Ganjifard, Shokouh Ghafari, Adeleh Sahebnasagh, Mahboubeh Esmaeili, Ali Reza Amirabadizadeh, Azadeh Ebrahimzadeh, et al. (+2)
24 [GO] 2024―Sep―23 Artificial intelligence and COVID-19 vaccine hesitancy Sara Kamal Shahsavar, Arman Alinezhad, Masoud Keikha
25 [GO] 2024―Jul―31 Psychological characteristics and their impact on the efficacy and safety of COVID-19 vaccines Mohsen Karbalaei, Vahideh Poyesh, Masoud Keikha
26 [GO] 2024―Jul―17 Association of C4 and CH50 levels with cough and rhinorrhea in COVID-19 patients: A retrospective analysis in the Iranian population Seyed Ali Hashemi, Forouzan Rostami, Babak Shaghaghi, Mahla Niknam, Elham Abani, Abdol Sattar Pagheh, et al. (+2)
27 [GO] 2024―Jun―28 Social media as a supporting mechanism during COVID-19 in Indonesia: A quantitative study on isolation among elders Mustain Mashud, Muhammad Saud, Rachmah Ida, Asia Ashfaq
28 [GO] 2024―Jun―25 Importancia de las agencias reguladoras nacionales y los laboratorios nacionales de control ante la pandemia de COVID-19: experiencia de la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) Imelda Rocío Guzmán-Cervantes, Elías Parra-Hernández, Alejandro Ernesto Svarch-Pérez, Armida Zúñiga-Estrada, Jorge C. Alcocer-Varela
29 [GO] 2024―May―22 Efecto de la vacunación contra el SARS-CoV-2 sobre la coagulación en pacientes mayores de 60 años tratados con acenocumarol Isabel Almodóvar-Fernández, Antonio Real-Fernández, Manuel Jesús Romero Atanes, Carlos Andreu-Vilarroig, Miguel Ángel Beltrán-Viciano, María Francisca Monreal-Pérez
30 [GO] 2024―May―09 COVID-19 vaccination and concerns regarding the maternal and neonatal safety outcomes Abdolreza Narouiepour, Mohsen Karbalaei, Masoud Keikha
31 [GO] 2024―Apr―15 COVID-19 vaccine rumour and resistance in Indonesia: Analysing vaccine hesitancy and cultural myths circulated on online platforms Rachmah Ida, Sri Endah Kinasih, Syafrida Nurrachmi Febriyanti, Ratih Puspa, Muhammad Saud, Mohd Syuhaidi Abu Bakar
32 [GO] 2024―Mar―28 Analysis of the level of protective serum antibody after third dose of different COVID-19 vaccines Atena Mansouri, Mitra Rafiee, Seyed-Alireza Esmaeili, Saboura Nikpour, Alireza Fereidouni, Mohammad Fereidouni
33 [GO] 2024―Mar―20 The impact of Omicron on the COVID-19 vaccines: A review Pragya D. Yadav, Deepak Y. Patil, Rima R. Sahay, Anita M. Shete, Sreelekshmy Mohandas, Velu Nair
34 [GO] 2024―Mar―07 Post COVID-19 era: Re-emergence of known and future (X) viral pathogens Pryanka Thakur, Vikram Thakur, Monika Sapra, Sonakshi Srivastava, Sanjay Kumar Singh Patel
35 [GO] 2024―Mar―05 Vacunación COVID-19 y búsquedas web sobre salud mental: un estudio infodemiológico mundial Juan Antonio Becerra-García, Sara Barbeito, Teresa Sánchez-Gutiérrez
36 [GO] 2024―Feb―15 Mecanismos inmunitarios innatos y adaptativos de las vacunas COVID-19. Efectos adversos graves asociados a la vacunación contra el SARS-CoV-2: una revisión sistemática Rocío Morlanes Pallás
37 [GO] 2024―Jan―18 Variantes genéticas rs1800629 en TNF y rs2228145 en IL6R: asociación con eventos supuestamente atribuibles a la vacunación e inmunización (ESAVI) y anticuerpos neutralizantes contra SARS-CoV-2 en la población del occidente de México vacunada con AZD1222 Axel Jair Villa-Panduro, Narda M. Corona-Reynaga, Dennis A. Meza-Peña, Mayra Alejandra Enciso Ramírez, Astrid Selene Espinoza García, Jorge Galindo-García, et al. (+4)
38 [GO] 2024―Jan―11 Knowledge, attitudes, and adherence of the Cape Verdean population to the COVID-19 vaccine Maria de Fátima Carvalho Alves, Janice de Jesus Soares, Maria da Luz Lima Mendonça
39 [GO] 2023―Dec―12 Exploring the psychological impact of anxiety, depression, and quality of life in patients with comorbid disease conditions post COVID-19 pandemic era Anmar Al-Taie, Dania A. Mohd Khalaf, Oritsetimeyin Arueyingho
40 [GO] 2023―Nov―28 Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform Fahime Edalat, Fatemeh Hosseini Tabatabaie, Afagh Moattari, Arash Letafati, Jamal Sarvari, Seyed Younes Hosseini
41 [GO] 2023―Nov―10 The prevalence of post-COVID-19 vaccination syndrome and quality of life among COVID-19-vaccinated individuals Yogendra Shrestha, Rajesh Venkataraman
42 [GO] 2023―Oct―16 Musculoskeletal and neuromuscular dysfunction due to covid-19 infection: A review Vivek Chauhan, Akash Pandey, Adrija Rakshit, Gaytri Mahajan, Shamsher S. Kanwar, Vivek Kumar Dhiman, Devendra Singh
43 [GO] 2023―Oct―05 Attitudes and concerns of Turkish nursing students against the COVID-19 vaccine, willingness to be vaccinated: A cross-sectional study Zeynep Daşıkan, Mashood Katuntu Waiswa
44 [GO] 2023―Oct―05 Impacto de la vacunación en la mortalidad de adultos colombianos con síndrome de dificultad respiratoria aguda por SARS-CoV-2 que requirieron ventilación mecánica invasiva Yina Daniela Benítez Patiño, Luis Carlos Triana, Oscar Mauricio Muñoz Velandia, Viviana Yiset López Ramírez, Laura María Niño Guerra, Santiago Bottia Córdoba
45 [GO] 2023―Oct―05 The co-infection of SARS-CoV-2 with atypical bacterial respiratory infections: A mini review Fateme Taheri, Soheil Vesal, Parnian Goudarzi, Zahra Sahafnejad, Amin Khoshbayan
46 [GO] 2023―Sep―15 Vacunación frente al SARS-CoV-2 en otoño de 2023: ¿a quién y cómo hay que vacunar? Fernando Moraga-Llop, Magda Campins-Martí
47 [GO] 2023―Aug―31 COVID-19 vaccines, perceptions and trust amongst vaccine refusers: A qualitative thematic analysis study Deldar Morad Abdulah, Hawar Abdulrazaq Mohammedsadiq, Pranee Liamputtong
48 [GO] 2023―Aug―30 To assess mortality from COVID-19 in patients with comorbidities, it is crucial to perform an autopsy Josef Finsterer
49 [GO] 2023―Aug―30 Vaccination impact on long COVID sequelae; a perspective view Farhad Dadgar, Fatemeh Dehghani, Farzaneh Peikfalak, Masoud Keikha
50 [GO] 2023―Jun―29 Exploring the Intention and Hesitancy to Receive a Booster Dose of COVID-19 Vaccine among Patients with Comorbid Disease Conditions Using a Health Belief Model. Anmar AL-TAIE, Zekiye K. YILMAZ
51 [GO] 2023―Jun―24 Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria Alejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
52 [GO] 2023―May―26 Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece. Petros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, et al. (+3)
53 [GO] 2023―May―18 ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION AMONG PREGNANT WOMEN ATTENDING PRIMARY HEALTH CENTERS: AN ACTIVE-SURVEILLANCE STUDY. Narayana Goruntla, Basappa Karisetty, N. Nandini Reddy, Bharadwaj Bhupasamdram, Himaja Reddy Ganireddy, Kasturi Vishwanathasetty Veerabhadrappa, et al. (+2)
54 [GO] 2023―May―18 COVID-19 Immune Response In Adults Post Measles-Rubella Vaccination. Suwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito
55 [GO] 2023―May―18 El fin de la urgencia internacional de salud pública por COVID-19: ¿y ahora qué? Núria Torner
56 [GO] 2023―May―04 Impact of Vaccination on the Entire Population and Dose-Response Relation of COVID-19 Abdul Malek, Ashabul Hoque
57 [GO] 2023―Apr―25 The status of COVID-19 vaccines in India: A Review. Deepak Kumar Jha, Kumar Pranay, Amit Kumar, Niti Yashvardhini
58 [GO] 2023―Apr―10 The Polymorphisms of TNF-α Related-gene and Antibody Production Following Third Dose of COVID-19 Vaccination: A Pilot Study. Phey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar
59 [GO] 2023―Mar―06 IMPACTO DE LA VACUNACIÓN CONTRA SARS-CoV-2 EN LA INCIDENCIA DE INFECCIÓN EN ÁMBITO ESCOLAR. María Teresa Herrero Diez, María Inés Salado Valdivieso, Sara Carbajal Domínguez, Marta Allué Tango, Juan Carlos Villa Caballero, Clara Berbel Hernández
60 [GO] 2023―Mar―02 An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13. Sushant Kumar, Khushboo Kumari, Gajendra Kumar Azad
61 [GO] 2023―Feb―13 Demographic and clinical characteristics and outcomes of COVID-19 patients admitted to a university hospital in the west of Iran: a retrospective study in the third wave. Younes Jesmani, Arezoo Bozorgomid, Fatemeh Khosravi Shadmani, Ali Dehbani, Babak Sayad
62 [GO] 2023―Jan―25 Incidence of sudden sensorineural hearing loss associated with BNT162b2 COVID-19 vaccine: Pooled results from register-based nationwide studies Paulo Ricardo Martins-Filho
63 [GO] 2023―Jan―17 FACTORES ASOCIADOS A LA INTENCIÓN DE VACUNACIÓN CONTRA EL COVID-19, EN POPAYÁN, CAUCA COLOMBIA Omar Andrés Ramos Valencia, Yuliana Buitrón Gonzalez, Jorge Sotelo Daza, Andrés Felipe Villaquiran
64 [GO] 2022―Dec―27 Optic neuritis associated with COVID-19-related vaccines Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
65 [GO] 2022―Dec―26 Vacunación frente a la COVID-19 a partir de los 6 meses de edad. Completando el círculo de la prevención en pediatría. Fernando Moraga-Llop
66 [GO] 2022―Dec―13 Knowledge And Attitudes Toward the COVID-19 Vaccine Among India's General Rural Population Rajesh Venkataraman, Umesh Yadav, Yogendra Shrestha, Sindhu Shree Narayanaswamy, Shree Harsha Pura Basavaraju
67 [GO] 2022―Nov―04 Determination of Binding Affinity of Tunicamycin with SARS-CoV-2 Proteins: Proteinase, Protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, Envelope and RBD of Spike Glycoprotein Ali Adel Dawood
68 [GO] 2022―Nov―01 The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19 Ali AliMohammadi, Nahid Chazani-Sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad
69 [GO] 2022―Nov―01 Differences in elderly stress levels before Covid-19 vaccination: History of exposure to Covid-19 reduces stress before vaccination Kristian Budi Setiawan, Isna Hikmawati, Dita Pratiwi Kusuma Wardani, Juanita Juanita
70 [GO] 2022―Oct―19 IR-7968. Enfermedad invasiva por neumococo en 2021. Impacto de la pandemia de COVID-19 C. Izquierdo Gómez, N. Soldevila Pidemunt, J. García-García, B. Viñado, A. Díaz-Conradi, Grupo de trabajo Barcino
71 [GO] 2022―Oct―19 IE-7919. Reticencias vacunales COVID-19 M.C. Gómez Moreno, M.B. Laorden Ochando, S. Sánchez Manresa, M. Pérez Martínez, M. Zornoza Moreno, J.J. Pérez Martín
72 [GO] 2022―Oct―19 IE-7884. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como refuerzo heterólogo en individuos previamente vacunados contra la COVID-19 S. de Cambra Florensa, J. Corominas Garia, M.T. Prat Cabañas, E. Torroella Busquets
73 [GO] 2022―Oct―19 IE-7881. Reactogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como refuerzo heterólogo: diferencias según la vacunación primaria previamente recibida y según el historial de infección de COVID-19 C. Borralleras Fumaña, J. Corominas García, M.T. Prat Cabañas, L. Ferrer Soler, I. Güell Casellas, E. Torroella Busquets
74 [GO] 2022―Oct―19 IE-7717. Los Servicios de Urgencias como aliados en la notificación de sospecha de reacciones adversas asociadas a la vacunación COVID-19 I. González-Iglesias, M. Fernández-Prada, E. Martín-Aragonés, P. Penanes-Alonso, P. Cienfuegos-González, M.J. Zapico-Baragaño
75 [GO] 2022―Oct―19 IR-7922. Comparación de 2 brotes de COVID-19 acaecidos antes y después de la vacunación de usuarios y trabajadores de una residencia geriátrica G. Parisé Farreny, J. Rosinach Bonet, N. Rosell Solé, J.P. Bamala Zuriguel, I. Mòdol Pena, X. Farré Pueyo
76 [GO] 2022―Oct―19 EE-7888. Campaña de captación (catch-up) con COVID-19 en gestantes: implementación y resultados M. Fernández-Prada, A. Sánchez del Río, C.I. González-González, E. Martín-Aragonés, L. López-Fernández, P. Cienfuegos-González
77 [GO] 2022―Oct―19 ER-7932. Experiencia de vacunación frente al COVID-19 en las personas de muy alto riesgo en el Servicio de Medicina Preventiva y Salud Pública de un hospital de tercer nivel N. Manrique Vinagre, M.M. Guerra Hernández, V. Fernández Espinilla, N. Khynku Khshyva, C. De Álvaro García, M. Martínez Retortillo
78 [GO] 2022―Oct―19 IR-7936. Características epidemiológicas de las reinfecciones por COVID-19 en los trabajadores sanitarios A. Pérez Dalí, R. García Rodríguez, M.J. Pereira Rodríguez, I. Díaz Vázquez, F. Freijedo Fariñas, M.M. Castro Rivas
79 [GO] 2022―Oct―19 EE-7853. Campaña de captación (catch-up) con COVID-19 en pacientes hospitalizados: implementación y resultados P. Cienfuegos-González, E. Madrid-Álvarez, M. Fernández-Prada, M.J. Zapico-Baragaño, E. Martín-Aragonés, L. López-Fernández
80 [GO] 2022―Oct―19 ER-7972. Características de los profesionales vacunados frente al COVID-19 en un hospital de tercer nivel E. García Carrasco, D.M. López Garizado
81 [GO] 2022―Oct―19 EE-7978. Implementación de la campaña de vacunación frente a COVID-19 en un hospital de tercer nivel L.P. Cabrera-Miranda, A. García De Codes Ilario, S. de Miguel García, N. Rosillo Ramírez, E.M. Medrano Monteagudo, M.P. Gil Martínez, M.P. Arrazola Martínez
82 [GO] 2022―Oct―19 IE-7971. Perfil clínico y demográfico de los pacientes candidatos a recibir Evusheld® para la prevención de la COVID-19 grave, en un hospital de tercer nivel E. García Verduguez, N. Rosillo Ramírez, S. de Miguel García, A. García de Codes, L.P. Cabrera Miranda, P. Arrazola Martínez
83 [GO] 2022―Oct―19 IR-7641. Cobertura vacunal antineumocócica en pacientes mayores de 65 años hospitalizados por la enfermedad de SARS-CoV-2 M.T. Herrero Díez, M.M. Guerra Hernández, V. Fernández Espinilla, M.C. Viña Simón, C. Hernán García, J.J. Castrodeza Sanz
84 [GO] 2022―Oct―19 IE-7951. Evolución epidemiológica de los nuevos serotipos vacunales 22F y 33F de Streptococcus pneumoniae en España incluyendo el impacto de la pandemia por SARS-CoV-2 J. Sempere, S. Ruiz, D. Rico, S. de Miguel, M. Domenech, J. Yuste
85 [GO] 2022―Oct―19 IE-7950. Contribución de las vacunas conjugadas antineumocócicas y el SARS-CoV-2 a la resistencia a antibióticos en Streptococcus pneumoniae en España durante el periodo 2004-2020 J. Sempere, C. Pérez-García, D. Lago, S. Hita, M. Domenech, J. Yuste
86 [GO] 2022―Oct―19 IE-7967. Respuesta a la vacunación frente a SARS-CoV-2 con vacunas de ARNm en los pacientes inmunodeprimidos N. Rosillo Ramírez, A. García de Codes, L.P. Cabrera Miranda, S. de Miguel García, E. García Verduguez, P. Arrazola Martínez
87 [GO] 2022―Oct―19 IE-7925. Contribución de las vacunas antineumocócicas y la pandemia por SARS-CoV-2 en la evolución epidemiológica de la enfermedad neumocócica invasiva en España S. de Miguel, J. Sempere, S. Hita, J. Llorente, M. Domenech, J. Yuste
88 [GO] 2022―Oct―19 IR-7885. Seguridad de una vacuna de proteína recombinante basada en un heterodímero de fusión del dominio de unión al receptor del SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam S. de Cambra Florensa, C. Garriga Alsina, L. Ferrer Soler, E. Torroella Busquets
89 [GO] 2022―Oct―19 IR-7883. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam C. Borralleras Fumaña, C. Garriga Alsina, L. Ferrer Soler, E. Torroella Busquets
90 [GO] 2022―Oct―04 Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study Fazlollah Shokri, Saeed Rezapoor, Masoud Najafi, Mohsen Asadi, Mohammad Karimi alavije, Moussa Abolhassani, et al. (+9)
91 [GO] 2022―Sep―16 Vaccine hesitancy and the challenge of controlling COVID-19 and other vaccine-preventable diseases Paulo Ricardo Martins-Filho
92 [GO] 2022―Aug―30 Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study Seyede Faezeh Mousavi, Mohammadamin Ebrahimi, Seyed Amirhosein Ahmadpour Moghaddam, Narges Moafi, Mahbobe Jafari, Ayoub Tavakolian, Mohsen Heidary
93 [GO] 2022―Aug―30 Parents' perception of COVID-19 risk of infection and intention to vaccinate their children Hamdy Khaled Sabra, Mostafa Abdulraheem Bakr, Omar El Sayed Mohmed Rageh, Asmaa Khaled, Omnia Mohamed Elbakliesh, Ibrahim Ali Kabbash
94 [GO] 2022―Jul―19 Vacunaciones masivas contra el COVID-19 mediante el uso de las tecnologías para la gestión de la programación de citas y datos de grandes volúmenes de vacunados Alicia K. Rodas-Martinez, Josue R. Altamirano-Yupanqui
95 [GO] 2022―Jul―19 Menstrual abnormalities after COVID-19 vaccines: A systematic review Maheen Nazir, Shumaila Asghar, Muhammad Ali Rathore, Asima Shahzad, Anum Shahid, Alishba Ashraf Khan, et al. (+4)
96 [GO] 2022―Jul―04 Reasons for Individuals' COVID-19 vaccine hesitations and changing decisions over time: A longitudinal qualitative study Dicle Filiz Yıldırım, Pınar Serçekuş, Sevgi Özkan
97 [GO] 2022―Jun―22 COVID-19 Vaccines: Update of the vaccines in use and under development Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, Paulo R. Bignardi
98 [GO] 2022―Jun―20 COVID-19 vaccination acceptance in Jambi City, Indonesia: A single vaccination Center study Gilbert Sterling Octavius, Theo Audi Yanto, Rivaldo Steven Heriyanto, Haviza Nisa, Catherine Ienawi, H. Emildan Pasai
99 [GO] 2022―Jun―17 Multivalent vaccines against new SARS-CoV-2 hybrid variants Kiarash Ghazvini, Masoud Keikha
100 [GO] 2022―Jun―17 Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? Masoud Keikha
101 [GO] 2022―Jun―09 Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants Ali Adel Dawood
102 [GO] 2022―Jun―03 Early diagnosis and treatment of SARS-CoV-2 vaccination associated polyradiculitis to improve the outcome Josef Finsterer, Fulvio A. Scorza
103 [GO] 2022―Jun―01 Comparison of clinical, radiological and laboratory findings in discharged and dead patients with COVID-19 Mahbobe Jafari, Maryam Akbari, Maryam Navidkia, Shirin Dashtbin, Seyede Faezeh Mousavi, Mohsen Heidary, Saeed Khoshnood
104 [GO] 2022―Jun―01 COVID-19 vaccination coverage and associated factors in seasonal fruit workers in Lleida Carme Miret, Miquel Alsedà, Pere Godoy
105 [GO] 2022―May―30 Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain Christine Giesen, Carmen Saa-Requejo, Inmaculada Lopez-Carrillo, Angelica Ortega-Torres, Cristina García-Fernández
106 [GO] 2022―May―13 Intention to get COVID-19 vaccination and its associated predictors: A cross-sectional study among the general public in Algeria Mohamed Lounis, Samir Abdelhadi, Mohammed Amir Rais, Djihad Bencherit, Malik Sallam
107 [GO] 2022―Apr―28 Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou
108 [GO] 2022―Apr―28 Lack of COVID-19 vaccination in rural areas of Pakistan Alisha Saleem, Maha Rashid, Ameerah Shaikh, Sajjad Ali
109 [GO] 2022―Mar―24 The prevalence of inverse health consequences of COVID-19 vaccines: a post-vaccination study Yogendra Shrestha, Rajesh Venkataraman
110 [GO] 2022―Feb―14 Evaluación de la respuesta de anticuerpos IGG específicos contra SARS-COV-2 en personal de salud con esquema completo de vacuna sputnik V (GAM-COVID-VAC) Ezequiel Cordova, M. Ines Lespada, Diego Cecchini, Fabiola Nieto, Susana Palonski, Mariana Badran, et al. (+8)
111 [GO] 2022―Feb―11 Vacunación pediátrica frente a la COVID-19 más allá de la adolescencia. Otra realidad F. Moraga-Llop
112 [GO] 2022―Feb―02 Awareness, knowledge and acceptance of COVID-19 vaccine among the people of West Bengal, India: A web-based survey Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar, Kazi Monjur Ali, Biplab Giri, Amitava Pal, Sandeep Kumar Dash
113 [GO] 2022―Jan―26 Adenoviral vector-based COVID-19 vaccines-associated cerebral venous sinus thromboses: Are those adverse events related to the formation of neutrophil extracellular traps? Marian Simka
114 [GO] 2022―Jan―25 La GESTIÓN de la PANDEMIA de COVID-19 EN las RESIDENCIAS GERIÁTRICAS de CATALUÑA F.E.R.N.A.N.D.O. PARRILLA
115 [GO] 2022―Jan―06 Selection of new COVID-19 genotypes following mass vaccination: The Rotavirus model Pierfrancesco Lapolla, Pietro Familiari, Placido Bruzzaniti
116 [GO] 2021―Dec―03 Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies Niti Yashvardhini, Amit Kumar, Deepak Kumar Jha
117 [GO] 2021―Nov―04 Asociación entre la vacunación contra influenza y la mortalidad por COVID-19 Cesar A Arce-Salinas, Yamile N Esquivel-Torruco, Arely A Bejarano-Juvera, Aditi K Bustamante- Flores, Naomi Aguilar-Martínez, Jessica G Azcorra- López, et al. (+4)
118 [GO] 2021―Nov―04 Is there any effect of flu vaccine on the SARS-CoV-2 infected patients? D. El-Qutob, M. Nieto, L. Alvarez-Arroyo, FJ Carrera-Hueso
119 [GO] 2021―Sep―07 Zinc role in Covid-19 disease and prevention Alberto Boretti, Bimal K Banik
120 [GO] 2021―Sep―07 Assessment of attitude and hesitancy towards vaccine against COVID-19 in a Pakistani population: A mix methods survey Zainab Aqeel Khan, Raheel Allana, Irrum Afzal, Akbar Shoukat Ali, Omama Mariam, Reema Aslam, et al. (+8)
121 [GO] 2021―Sep―07 Predictive demographic factors of Covid-19 vaccine hesitancy in Venezuela: a cross-sectional study Gabriel Andrade
122 [GO] 2021―Sep―06 Attitudes of a Sample of Jordanian Young Adults toward Different Available COVID-19 Vaccines Walid Al-Qerem, Anan S Jarab, Raghda Qarqaz, Mohammad Al Hayek
123 [GO] 2021―Sep―01 Factors influencing the acceptability of COVID-19 vaccination: A cross-sectional study from Malaysia Roy Rillera Marzo, Absar Ahmad, Khadijah Abid, Asmita Priyadashini Khatiwada, Ali Ahmed, Thin Mon Kyaw, et al. (+5)
124 [GO] 2021―Aug―04 COVID-19 and primary care: a perspective from Italy F Ghidinelli, F Martire
125 [GO] 2021―Aug―04 Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 Nelson Alvis-Guzman
126 [GO] 2021―Jul―13 Diagnosis Of Covid-19 In Symptomatic Patients: An Updated Review MN Zahan, H. Habibi, A. Pencil, J. Abdul-Ghafar, SA Ahmadi, NS Juyena, et al. (+2)
127 [GO] 2021―Jul―13 Variantes de SARS-CoV-2, una historia todavía inacabada Marta Pérez-Abeledo, Juan Carlos Sanz
128 [GO] 2021―Jun―17 Discordant results of SARS-CoV-2 PCR-based tests in the early phase of pandemic in Indonesia: infection control consequences Agung Pranata, Baidillah Zulkifli, Sukmawan Fajar Santosa, Ade Oktiviyari, Zulfitri Zulfitri, Zinatul Hayati, et al. (+3)
129 [GO] 2021―May―28 Vacunación frente a la COVID-19 en los adolescentes. Una realidad Fernando Moraga-Llop
130 [GO] 2021―May―19 “Recomendaciones SEPAR y nuevos retos sobre la vacuna COVID-19 en las enfermedades respiratorias” David de la Rosa-Carrillo, José Luis López-Campos, Marina Blanco Aparicio, Felipe Villar-Álvarez
131 [GO] 2021―Apr―15 Los gobiernos y la vacunación contra la COVID-19 Mag Luz Javier
132 [GO] 2021―Apr―09 Impacto de las variantes genéticas de la espícula en las vacunas frente al SARS-CoV-2 Jordi Reina, Pablo Fraile-Ribot
133 [GO] 2021―Apr―05 Retrospective and prospective application of robots and artificial intelligence in global pandemic and epidemic diseases A. Yoganandhan, G. Rajesh Kanna, S.D. Subhash, J. Hebinson Jothi
134 [GO] 2021―Mar―12 Myths and conspiracy theories on vaccines and COVID-19: Potential effect on global vaccine refusals Irfan Ullah, Kiran Shafiq Khan, Muhammad Junaid Tahir, Ali Ahmed, Harapan Harapan
135 [GO] 2021―Feb―26 The Vaccine-Condition Or Vaccination Passport And Its Eventual Fit Into A Broad Recommended Vaccination Framework Against Covid-19 César Cierco Seira
136 [GO] 2021―Jan―22 The role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic Alessandra La Gatta, Federico Ghidinelli
137 [GO] 2020―Nov―25 Mareo al volar irresoluble asociado a la infección por COVID-19: caso clínico Hamze Shahali, Amin Talebi Bezmin Abadi, Azade Amirabadi Farahani, Mohammad Darvishi
138 [GO] 2020―Oct―14 ¿Cómo será la segunda ola del terrible COVID-19 con el número creciente de casos infectados y mortalidad en Iraq? Ali Adel Dawood, Zahra Adel Dawood
139 [GO] 2020―Oct―14 Novel Coronavirus 2019 (COVID-19) Pandemic Outbreak: A Comprehensive Review of the Current Literature Hayat Ullah, Asad Ullah, Anbareen Gull, Tayyaba Mousavi, Muhammad Waseem Khan
140 [GO] 2020―Oct―03 Glicosilación, sitios de unión de ligandos y variaciones antigénicas entre la glicoproteína de membrana del COVID-19 y los coronavirus asociados Ali Adel Dawood
141 [GO] 2020―Sep―14 Tendencias epidémicas en los diez principales países con más casos de COVID-19 en comparación con Turquía Veli Durmuş
142 [GO] 2020―Sep―12 Are social distancing, hand washing and wearing masks can mitigate the transmission of COVID-19? Natesan Manikandan
143 [GO] 2020―Jul―04 Recuperando las coberturas vacunales perdidas en la pandemia COVID-19 F.A. Moraga-Llop, M. Fernández-Prada, A.M. Grande-Tejada, L.I. Martínez-Alcorta, D. Moreno-Pérez, J.J. Pérez-Martín
144 [GO] 2020―Jul―04 Collateral effects of Covid-19 pandemic emergency response on worldwide immunizations Nuria Torner
145 [GO] 2020―Jun―13 A review on Promising vaccine development progress for COVID-19 disease Tafere Mulaw Belete
146 [GO] 2020―Apr―18 Vacunas contra el coronavirus L. Urbiztondo, E. Borras, G. Mirada
147 [GO] 2020―Apr―04 El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo J. Reina
 [1] 

147 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.023 sec